Muscular nitric oxide synthase (muNOS) and utrophin

Journal of Physiology Paris

Volumn 96, Issue 1-2, 2002, Pages 43-52

  Chaubourt, Emmanuel ^a   Voisin, Vincent ^a   Fossier, Philippe ^a   Baux, Gérard ^a   Israël, Maurice ^a   De La Porte, Sabine ^a  

^a LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

Author keywords

DMD; Dystrophin; Mdx; Nitric oxide; Nitric oxide synthase; Utrophin

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UTROPHIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BECKER MUSCULAR DYSTROPHY; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; ENZYME LOCALIZATION; GENE THERAPY; MOUSE; MYOBLAST; MYOTUBE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PROTEIN CONTENT;

ANIMALS; ARGININE; BLOTTING, WESTERN; CELLS, CULTURED; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; REFERENCE VALUES; THIGH; UTROPHIN;

EID: 0036148295     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(01)00079-1     Document Type: Article

References (112)

1. Enzymatic function of nitric oxide synthases
2. Assembly of postsynaptic apparatus
3. Nitric oxide release is present from incubated skeletal muscle preparations
4. Evidence that nitric oxide increases glucose transport in skeletal muscle
5. Atypical neural messengers
6. Utrophin: A structural and functional comparison to dystrophin
7. Nitric oxide synthase (NOS) in mouse skeletal muscle development and differentiated myoblasts
8. NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy
9. Synaptic signaling by nitric oxide
10. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
11. Interaction of nitric-oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains
12. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
13. X chromosome-linked muscular dystrophy (mdx) in the mouse
14. Utrophin to the rescue
15. Feline muscular dystrophy with dystrophin deficiency
16. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy
17. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy
18. Nitric oxide synthase and cyclic GMP-dependent protein kinase concentrated at the neuromuscular endplate
19. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase
20. Nitric oxide synthase (NOS) I during postnatal development in rat and mouse skeletal muscle
21. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs
22. Myogenic cells for the therapy of primary myopathies: Wishful thinking or therapeutic perspective
23. Mdx muscle pathology is independent of nNOS perturbation
24. Challenges in Duchenne muscular dystrophy
25. Nitric oxide actions in neurochemistry
26. Characteristics of skeletal muscle in mdx mutant mice
27. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice
28. Expression of truncated utrophin leads to major funtional improvements in dystrophin-deficient muscles of mice
29. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice
30. Dystrophinopathies
31. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
32. Présence d'une protéine de type dystrophine au niveau de la jonction neuromusculaire dans la dystrophie musculaire de Duchenne et la souris mutante "mdx"
33. Localization of nitric oxide synthase in human skeletal muscle
34. 1H-(1, 2, 4) oxadiazolo (4, 3a) quinoxalin-l-one
35. Understanding dystrophinopathies: An inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse
36. Nitric oxide synthase I (NOS I) is a costameric enzyme in rat skeletal muscle
37. Subtle neuromuscular defects in utrophin-deficient mice
38. Local transcriptional control of utrophin expression at the neuromuscular synapse
39. Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism
40. Induction of utrophin gene expression by heregulin in skeletal muscle cells: Role of the N-box motif and GA binding protein
41. Lipid peroxidation in children with Duchenne's hereditary myopathy
42. Nitric oxide synthase in skeletal muscle fibers: A signaling component of the dystrophin-glycoprotein complex
43. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle
44. Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic striated muscle fibers
45. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin
46. Absence of nitric oxide synthase I despite the presence of the dystrophin complex in human striated muscle
47. Oxidative damage to muscle protein in Duchenne muscular dystrophy
48. Differential protein oxidation in Duchenne and Becker muscular dystrophy
49. Nitric oxide release and contractile properties of skeletal muscles from mice deficient in type III NOS
50. Inhibition of nitric oxide synthase as a potential therapeutic target
51. Dystrophin: The protein product of the Duchenne muscular dystrophy locus
52. Cell and fiber-type distribution of dystrophin
53. Expression of nitric oxide synthase isoforms in normal ventilatory and limb muscles
54. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
55. αl-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration
56. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action
57. Localization and quantification of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle
58. Immunolocalisation and developmental expression of dystrophin related protein in skeletal muscle
59. Nitric oxide in skeletal muscle
60. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships
61. Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle
62. Nitric oxide synthase is concentrated at the skeletal muscle endplate
63. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide
64. Nitric oxide as a messenger molecule for myoblast fusion
65. Differences in both inositol 1,4,5,-triphosphate mass and inositol 1,4,5-triphosphate receptors between normal and dystrophic skeletal muscle cell lines
66. Utrophin is a regeneration-associated protein transiently present at the sarcolemma of regenerating skeletal muscle fibers in dystrophin-deficient hypertrophic feline muscular dystrophy
67. Postnatal development of nitric oxide synthase activity in fast and slow muscles of the rat
68. An autosomal transcript in skeletal muscle with homology to dystrophin
69. In situ identification of neuronal nitric oxide synthase (NOS-I) mRNA in mouse and rat skeletal muscle
70. Effects of nitric oxide on the contraction of skeletal muscle
71. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle
72. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects
73. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene
74. Nitric oxide: Discovery and impact on clinical medecine
75. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle
76. Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle
77. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle
78. Accumulation of NO synthase (type-1) at the neuromuscular junctions in adult mice
79. Dystrophin-associated proteins in muscular dystrophy
80. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues
81. Respiratory muscles as a target for adenovirus-mediated gene therapy
82. Nitric oxide synthase isoenzymes antibodies
83. A homologue of dystrophin is expressed at the neuromuscular junction of normal individuals and DMD patients and of normal and mdx mice
84. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice
85. Role of nitric oxide in skeletal muscle: Synthesis, distribution and functional importance
86. Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimulation in vivo
87. Nitric oxide synthase in rat neuromuscular junctions and in nerve terminals of Torpedo electric organ: Its role as regulator of acetylcholine release
88. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
89. Neuronal nitric-oxide synthasemu, an alternatively spliced isoform expressed in differentiated skeletal muscle
90. Immunobiology and the future of myoblast transfer therapy
91. Physiology of nitric oxide in skeletal muscle
92. Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice
93. Expression of different isoforms of nitric oxide synthase in experimentally denervated and reinnervated skeletal muscle
94. Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle
95. Expression of the inductible nitric oxide synthase gene in diaphragm and skeletal muscle
96. Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle
97. Utrophin: A potential replacement for dystrophin
98. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
99. Expression of full-length utrophin prevents muscular dystrophy in mdx mice
100. Utrophin mRNA expression in muscle is not restricted to the neuromuscular junction
101. Ultrastructural localization of alpha 1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin
102. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses
103. Neuronal NOS: Gene structure, mRNA diversity, and functional relevance
104. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy
105. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase
106. Translating stem and progenitor cell biology to the clinic: Barriers and opportunities
107. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes
108. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species
109. Immunolocalization of nitric oxide synthases at the postsynaptic domain of human and rat neuromuscular junctions-Light and electron microscopic studies
110. Neurobiology of nitric oxide
111. Developmental studies of dystrophin-positive fibers in mdx, and DRP localization